Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/24 08:25 | 8/16/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Bigal Marcelo | FL | D | P | 20 | 13.25 | 0 | 2 | 18 | 10 | D | |||||||||||||||
8/19/24 08:25 | 8/16/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Brege Laura | FL | D | P | 13 | 12.81 | 0 | 1 | 6 | 18 | D | |||||||||||||||
8/14/24 16:35 | 8/14/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Yang Michael J. | FL | D | P | 26 | 12.90 | 0 | 2 | 38 | 7 | D | |||||||||||||||
8/13/24 16:55 | 8/12/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Lee Frank D. | FL | DO | CEO | P | 100 | 12.10 | 0 | 8 | 8 | 108 | D | ||||||||||||||
8/13/24 08:43 | 8/12/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Bigal Marcelo | FL | D | P.a | 41 | 12.01 | 0 | 3 | 65 | 9 | D | |||||||||||||||
8/12/24 20:33 | 8/12/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Froimson Mark | FL | D | P | 16 | 11.58 | 0 | 1 | 11 | 14 | D | |||||||||||||||
8/12/24 20:33 | 8/12/24 | PCRX | Health | Drug | Pharmaceutical Preparations | Bigal Marcelo | FL | D | P | 41 | 12.01 | 0 | 3 | 65 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |